Are you Dr. Shaw?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 62 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
619 19th Street South
Birmingham, AL 35233Phone+1 205-934-6600
Summary
- Dr. George Shaw, MD is an oncologist in Birmingham, Alabama. He is currently licensed to practice medicine in Alabama, Pennsylvania, and Michigan.
Education & Training
University of MichiganResidency, Internal Medicine, 1980 - 1983
Ohio State University College of MedicineClass of 1980
Certifications & Licensure
PA State Medical License 2013 - 2024
AL State Medical License 1985 - 2022
MI State Medical License 1981 - 1985- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Investigator Alumnus Howard Hughes Medical Institute, 1997
Publications & Presentations
PubMed
- 152 citationsVertical T cell immunodominance and epitope entropy determine HIV-1 escapeMichael K. P. Liu, Natalie Hawkins, Adam J. Ritchie, Vitaly V. Ganusov, Victoria E. Whale
The Journal of Clinical Investigation. 2012-12-10 - 983 citationsAntiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.Persephone Borrow, Hanna Lewicki, Xiping Wei, Marc S. Horwitz, Nancy J. Peffer
Nature Medicine. 1997-02-01 - 1318 citationsEmergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) MonotherapyXiping Wei, Julie M. Decker, Hongmei Liu, Zee Zhang, Ramin B. Arani
Antimicrobial Agents and Chemotherapy. 2002-06-01
Grant Support
- Penile Transmission And Neutralization Of Pathogenic SivsmmNational Institute Of Allergy And Infectious Diseases2011–2012
- VirologyNational Institute Of Allergy And Infectious Diseases2011
- Penile Transmission And Neutralization Of Pathogenic SivsmmNational Institute Of Allergy And Infectious Diseases2011
- Novel Sivsmm Strains For Analysis Of Mucosal Transmission And Vaccine ProtectionNational Institute Of Allergy And Infectious Diseases2011
- Cloning, Characterization And In Vivo Testing Of Mucosally Transmitted SIVNational Institute Of Allergy And Infectious Diseases2011
- Molecular Analysis Of The Mucosal Sivsmm Transmission BottleneckNational Institute Of Allergy And Infectious Diseases2010–2011
- Cloning, Characterization And In Vivo Testing Of Mucosally Transmitted SIVNational Institute Of Allergy And Infectious Diseases2010–2011
- AdministrationNational Institute Of Allergy And Infectious Diseases2010–2011
- Novel Sivsmm Strains For Analysis Of Mucosal Transmission And Vaccine ProtectionNational Institute Of Allergy And Infectious Diseases2010
- Biophysical/Genetic Properties Of HIV1 In Human PlasmaNational Institute Of Allergy And Infectious Diseases1998–2007
- HIV Acute Infection &Early Disease UnitNational Institute Of Allergy And Infectious Diseases1997–2001
- Biophysical &Genetic Properties Of HIV In Human PlasmaNational Institute Of Allergy And Infectious Diseases1996–1997
- Vif And HIV Entry And ReplicationNational Institute Of Allergy And Infectious Diseases1993–1997
- Central Virus CoreNational Institute Of Allergy And Infectious Diseases1988–1993
- Molecular Characterizion Of HTLV-III/LAV In VivoNational Institute Of Allergy And Infectious Diseases1986–1988
